Construction of an immune-related signature with prognostic value for colon cancer

BACKGROUND: Colon cancer is the third most common malignant tumor in the world. Although immunotherapy has been used in cancer treatment, there is still no first-line immunotherapy method for colon cancer. Therefore, it is essential to search for potential immunotherapy targets and molecular biomark...

Descripción completa

Detalles Bibliográficos
Autores principales: Lv, Yunxia, Wang, Xinyi, Ren, Yu, Fu, Xiaorui, Li, Taiyuan, Jiang, Qunguang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2021
Materias:
Bioinformatics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8106397/
https://www.ncbi.nlm.nih.gov/pubmed/33996273
http://dx.doi.org/10.7717/peerj.10812

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8106397/
https://www.ncbi.nlm.nih.gov/pubmed/33996273
http://dx.doi.org/10.7717/peerj.10812

Ejemplares similares